Generics reduce England’s drug spending

Generics and biosimilars Initiative

Building trust in cost-effective treatments

Inscribirse
eng / esp

Generics reduce England’s drug spending

INICIO/Informes | Posted 17/08/2012 0 Post your comment

According to a new report from the National Health Service in England, published on 31 July 2012, despite a 3.8% increase in the number of prescriptions dispensed in 2011 compared to 2010, spending on pharmaceuticals has decreased by 0.3%.

The number of prescription items increased by 34.9 million from 926.7 million in 2010 to 961.5 million in 2011. This represents an increase of 3.8% in 2011 compared to 2010 and an increase of 63.8% (374.5 million items) compared to 2001.

Between 2001 and 2011, the net ingredient cost of prescription items dispensed fell by GBP 29.3 million (0.3%) to GBP 8,805.1 million.

In 2011, the average number of prescriptions dispensed per head of population increased to 18.3 compared to 17.7 items in 2010, representing a 2.9% increase. However, despite this increase the average cost per head of population fell from GBP 169.13 in 2010 to GBP 167.22 in 2011, representing a fall of 1.1%. The average net ingredient cost per prescription item has fallen from GBP 9.53 in 2010 to GBP 9.16 in 2011. This is the seventh year that England has seen such a reduction.

Most of the savings are attributed to increased generics use by patients due to generic versions of some drugs becoming available. In 2011, generics accounted for 68.9% of all prescription items compared to 67.4% in 2010. Generics represented 29.8% of the total drug spending in England in 2011 compared to 29.6% in 2010. This represents a huge increase in the use of generics compared to in 2001, when generics accounted for 52.2% of prescription items, but only 17.8% of the cost.

The generic drugs attributed with contributing to the fall in costs include proton-pump inhibitor, esomeprazole; hormone antagonist, anastrazole; transplant-rejection treatment mycophenolate and glaucoma treatments dorzolamide with timolol and brimonidine tartrate.

The drug with the greatest increase in the number of items dispensed (2.6 million items) was omeprazole.

Related articles

UK gets value for money for its medicines

Members of parliament to hold inquiry into UK drug shortages

UK scraps generic substitution plans

Permission granted to reproduce for personal and educational use only. All other reproduction, copy, retransmission or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Source: NHS